Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Functional variable number of tandem repeats variation in the promoter of proto-oncogene PTTG1IP is associated with risk of estrogen receptor-positive breast cancer.

Cancer science - 1 Jun 2012

Xiang Chan, Gao Haidong, Meng Lei, Qin Zhaoyu, Ma Rong, Liu Yang, Jiang Yan, Dang Chengxue, Jin Li, He Fuchu, Wang Haijian

Abstract excerpt

Genetic polymorphisms in the signalling pathway of estrogen receptor (ER) could modify the risk of breast cancer. A variable number of tandem repeats (VNTR) polymorphism in the promoter of PTTG1IP, pituitary tumor transforming gene binding factor targeted by estrogen receptor α (ERα) in endocrine...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Breast Neoplasms
Share to Cell Line, Tumor
Share to Estrogen Receptor alpha

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Intracellular Signaling Peptides and Proteins

Share to Membrane Proteins

Share to Minisatellite Repeats

Share to Proto-Oncogene Mas

Share to Tandem Repeat Sequences

Source

Open in PubMed Open full text

Identifiers

PMID: 22404099
DOI: 10.1111/j.1349-7006.2012.02266.x
PMCID: PMC7685090

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-22404099-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Functional variable number of tandem repeats variation in the promoter of proto-oncogene PTTG1IP is associated with risk of estrogen receptor-positive breast cancer.PMID 22404099Read ↗

Associations of genetic variants in the estrogen receptor coactivators PPARGC1A, PPARGC1B and EP300 with familial breast cancer.Semantic proximity Read ↗

Genetic variation of ESR1 and its co-activator PPARGC1B is synergistic in augmenting the risk of estrogen receptor-positive breast cancer.Semantic proximity Read ↗

Association of breast cancer risk with a GT dinucleotide repeat polymorphism upstream of the estrogen receptor-alpha gene.Semantic proximity Read ↗

Polymorphisms in genes of the steroid receptor superfamily modify postmenopausal breast cancer risk associated with menopausal hormone therapy.Semantic proximity Read ↗

Polymorphic AAAG repeat length in estrogen-related receptor gamma (ERRγ) and risk of breast cancer in Iranian women.Semantic proximity Read ↗

A long AAAG repeat allele in the 5' UTR of the ERR-γ gene is correlated with breast cancer predisposition and drives promoter activity in MCF-7 breast cancer cells.Semantic proximity Read ↗

Complex 5′ Genomic Structure of the Human Prolactin Receptor: Multiple Alternative Exons 1 and Promoter UtilizationSemantic proximity Read ↗

Polymorphisms in ER-alpha gene interact with estrogen receptor status in breast cancer survival.Semantic proximity Read ↗

Genetic polymorphims of estrogen receptor alpha -397 PvuII (T>C) and -351 XbaI (A>G) in a portuguese population: prevalence and relation with breast cancer susceptibility.Semantic proximity Read ↗

GPR30 gene polymorphisms are associated with progesterone receptor status and histopathological characteristics of breast cancer patients.Semantic proximity Read ↗

A functional polymorphism in the promoter of the progesterone receptor gene associated with endometrial cancer risk.Semantic proximity Read ↗

Analysis of the ERalpha germline PvuII marker in breast cancer risk.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.